ICH S1A Need for carcinogenicity studies of pharmaceuticals

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/ICH/140/95
Effective from01/12/2013
KeywordsCarcinogenicity studies, tumorigenic potential, duration of treatment, genotoxicity
DescriptionThis document defines the conditions under which carcinogenicity studies should be conducted to avoid the unnecessary use of animals in testing.

Related content

How useful was this page?

Add your rating